Effect of twenty-four-week treatment with the antiestrogen EM-800 on estrogen-sensitive parameters in intact and ovariectomized mice

Endocrinology

Volumn 139, Issue 5, 1998, Pages 2645-2656

  Luo, Shouqi ^a   Sourla, Antigone ^a   Labrie, Claude ^a   Gauthier, Sylvain ^a   Merand, Yves ^a   Belanger, Alain ^a   Labrie, Fernand ^a,b  

^a LAVAL UNIVERSITY   (Canada)

^b UNIVERSITÉ LAVAL   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

4 [4 METHYL 2 [4 [2 (1 PIPERIDINYL)ETHOXY]PHENYL] 7 PIVALOYLOXY 2H 1 BENZOPYRAN 3 YLPHENYL] PIVALATE; 4 [7 (2,2 DIMETHYL 1 OXOPROPOXYL) 4 METHYL 2 [4 [2 (1 PIPERIDINYL)ETHOXY]PHENYL] 2H 1 BENZOPYRAN 3 YL] PHENYL 2,2 DIMETHYLPROPANOIC ACID; ANTIESTROGEN; ESTROGEN RECEPTOR; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BREAST CANCER; CONTROLLED STUDY; FEMALE; HISTOLOGY; HYPOTHALAMUS HYPOPHYSIS GONAD SYSTEM; MAMMARY GLAND; MOUSE; NONHUMAN; ORAL DRUG ADMINISTRATION; OVARIECTOMY; PRIORITY JOURNAL; RADIOIMMUNOASSAY;

EID: 0031765114     PISSN: 00137227     EISSN: None     Source Type: Journal    
DOI: 10.1210/endo.139.5.5994     Document Type: Article

References (34)

1. Mouridsen H, Palshof T, Patterson J, Battersby L 1978 Tamoxifen in advanced breast cancer. Cancer Treat Rev 5:131-141
2. Dickson RB, Lippman ME 1987 Estrogenic regulation of growth and polypeptide growth factor secretion in human breast carcinoma. Endocr Rev 8:29-43
3. Horwitz KB, McGuire WL 1978 Nuclear mechanism of estrogen action. Effect of estradiol and anti-estrogens on estrogen receptors and nuclear receptor processing. J Biol Chem 253:8185-8191
4. Rochefort H, Garcia M 1983 The estrogenic and antiestrogenic activities of androgens in female target tissues. Pharmacol Ther 23:193-216
5. 5-steroids in the ZR-75-1 human breast cancer cell line. Cancer Res 46:4933-4937
6. Asselin J, Kelly PA, Caron MG, Labrie F 1977 Control of hormone receptor levels and growth of 7,12-dimethylbenz(a)anthracene-induced mammary tumors by estrogens, progesterone and prolactin. Endocrinology 101:666-671
7. Chambraud B, Berry M, Redeuilh G, Chambon P, Baulieu EE 1990 Several regions of human estrogen receptor are involved in the formation of receptor-heat shock protein 90 complexes. J Biol Chem 265:20686-20691
8. Green S, Walter P, Kumar V, Krust V, Bornert JM, Argos P, Chambon P 1986 Human oestrogen receptor cDNA: sequence, expression and homology to v-erb-A. Nature 320:134-139
9. McNab MW, Tallarida RJ, Joseph R 1984 An evaluation of tamoxifen as a partial agonist by classical receptor theory, an explanation of the dual action of tamoxifen. Eur J Pharmacol 103:321-326
10. Furr BJ, Jordan VC 1984 The pharmacology and clinical uses of tamoxifen. Pharmacol Ther 25:127-205
11. Poulin R, Mérand Y, Poirier D, Lévesque C, Dufour JM, Labrie F 1989 Antiestrogenic properties of keoxifene, trans-4-hydroxytamoxifen and ICI164384, a new steroidal antiestrogen, in ZR-75-1 human breast cancer cells. Breast Cancer Res Treat 14:65-76
12. Wakeling AE, Bowler J 1988 Biology and mode of action of pure antiestrogens. J Steroid Biochem 30:141-147
13. Wakeling AE, Dukes M, Bowler J 1991 A potent specific pure antiestrogen with clinical potential. Cancer Res 51:3867-3873
14. Wakeling AE, Bowler J 1992 ICI 182,780, a new antioestrogen with clinical potential. J Steroid Biochem Mol Biol 43:173-177
15. Wakeling AE 1993 The future of new pure antiestrogens in clinical breast cancer. Breast Cancer Res Treat 25:1-9
16. Nique F, Van de Velde P, Brémaud J, Hardy M, Philibert D, Teutsch G 1994 11β-amidoalkoxyphenyl estradiols, a new series of pure antiestrogens. J Steroid Biochem Mol Biol 50:21-29
17. Labrie C, Martel C, Dufour JM, Lévesque C, Mérand Y, Labrie F 1992 Novel compounds inhibit estrogen formation and action. Cancer Res 52:610-615
18. Dauvois S, Geng CS, Lévesque C, Mérand Y, Labrie F 1991 Additive inhibitory effects of an androgen and the antiestrogen EM-170 on estradiol-stimulated growth of human ZR-75-1 breast tumors in athymic mice. Cancer Res 51:3131-3135
19. de Launoit Y, Dauvois S, Dufour M, Simard J, Labrie F 1991 Inhibition of cell cycle kinetics and proliferation by the androgen 5α-dihydrotestosterone and antiestrogen N-butyl-N-methyl-11-(16′α-chloro-3′, 17β-dihydroxy-estra-1′, 3′, 5′-(10′)triene-7′α-yl)undecanamide in human breast cancer ZR-75-1 cells. Cancer Res 51:2797-2802
20. Lévesque C, Mérand Y, Dufour JM, Labrie C, Labrie F 1991 Synthesis and biological activity of new halo-steroidal antiestrogens. J Med Chem 34:1624-1630
21. Simard J, Dauvois S, Haagensen DE, Lévesque C, Mérand Y, Labrie F 1990 Regulation of progesterone-binding breast cyst protein GCDFP-24 secretion by estrogens and androgens in human breast cancer cells: a new marker of steroid action in breast cancer. Endocrinology 126:3223-3231
22. Bradford MM 1976 A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 72:248-254
23. Asselin J, Labrie F 1978 Effects of estradiol and prolactin on steroid receptor levels in 7,12-dimethylbenz(a)anthracene-induced mammary tumors and uterus in the rat. J Steroid Biochem 9:1079-1082
24. Be′langer A, Caron S, Picard V 1980 Simultaneous radioimmunoassay of progestins, androgens, and estrogens in adult rat testis. J Steroid Biochem 13:185-190
25. Bélanger A, Labrie F, Monfette G, Dupont A, Caron S, Measurement of non conjugated C-19 steroids as well as C-19 steroid glucuronides in plasma and tissue. First International Symposium on Steroid Formation, Degradation and Action in Peripheral, Normal and Neoplastic Tissues, Taormina, Italy, 1989, 35 (Abstract)
26. Carson FL 1990 In: Borysewicz S (ed) Histotechnology. A Self-Instructional Text. ASCP Press, Chicago
27. Kramer CY 1956 Extension of multiple range tests to group means with unique numbers of replications. Biometrics 12:307-310
28. Korach KS 1994 Insights from the study of animals lacking functional estrogen receptor. Science 266:1524-1527
29. Guraya SS 1973 Morphology, histochemistry and biochemistry of follicular growth and atresia. Ann Biol Anim Biochem Biophys 13:320
30. Labrie C, Simard J, Zhao HF, Bélanger A, Pelletier G, Labrie F 1989 Stimulation of androgen-dependent gene expression by the adrenal precursors dehydroepiandrosterone and androstenedione in the rat ventral prostate. Endocrinology 124:2745-2754
31. Labrie F 1991 Intracrinology. Molecular and Cellular Endocrinology 78:C113-C118
32. Labrie F, Simard J, Luu-The V, Bélanger A, Pelletier G, Morel Y, Mebarki F, Sanchez R, Durocher F, Turgeon C, Labrie Y, Rhéaume E, Labrie C, Lachance Y 1996 The 3β-hydroxysteroid dehydrogenase/isomerase gene family, lessons from type II 3β-HSD congenital deficiency. In: Hansson V, Levy FO, Taskén K (eds) Signal Transduction in Testicular Cells. Ernst Schering Research Foundation Workshop. Springer-Verlag, New York, [Suppl 2], pp 185-218
33. Labrie F, Simard J, Luu-The V, Pelletier G, Belghmi K, Bélanger A 1994 Structure, regulation and role of 3β-hydroxysteroid dehydrogenase, 17β-hydroxysteroid dehydrogenase and aromatase enzymes in formation of sex steroids in classical and peripheral intracrine tissues. In: Sheppard MC, Stewart PM (eds) Hormone, Enzymes and Receptors. Baillière's Clinical Endocrinology and Metabolism, Baillière Tindall Ltd., London, pp 451-474
34. Martel C, Rhéaume E, Takahashi M, Trudel C, Couet J, Luu-The V, Simard J, Labrie F 1992 Distribution of 17β-hydroxysteroid dehydrogenase gene expression and activity in rat and and human tissues. J Steroid Biochem Mol Biol 41:597-603